These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7605624)

  • 1. FDG PET and differential diagnosis of dementia.
    Herholz K
    Alzheimer Dis Assoc Disord; 1995; 9(1):6-16. PubMed ID: 7605624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.
    Mielke R; Heiss WD
    J Neural Transm Suppl; 1998; 53():237-50. PubMed ID: 9700661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG PET imaging in patients with pathologically verified dementia.
    Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
    J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.
    Mielke R; Herholz K; Grond M; Kessler J; Heiss WD
    Neurobiol Aging; 1992; 13(1):93-8. PubMed ID: 1542386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia.
    Szelies B; Mielke R; Herholz K; Heiss WD
    Electroencephalogr Clin Neurophysiol; 1994 Aug; 91(2):131-9. PubMed ID: 7519142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
    Weinberger DR; Jones D; Reba RC; Mann U; Coppola R; Gibson R; Gorey J; Braun A; Chase TN
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):239-48. PubMed ID: 1498576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study.
    Ichimiya A; Herholz K; Mielke R; Kessler J; Slansky I; Heiss WD
    J Neurol Sci; 1994 May; 123(1-2):11-7. PubMed ID: 8064302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomographic studies of aging and Alzheimer disease.
    de Leon MJ; Ferris SH; George AE; Christman DR; Fowler JS; Gentes C; Reisberg B; Gee B; Emmerich M; Yonekura Y; Brodie J; Kricheff II; Wolf AP
    AJNR Am J Neuroradiol; 1983; 4(3):568-71. PubMed ID: 6410799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.
    Kessler J; Herholz K; Grond M; Heiss WD
    Neuropsychologia; 1991; 29(3):229-43. PubMed ID: 2057055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
    Farkas T; Ferris SH; Wolf AP; De Leon MJ; Christman DR; Reisberg B; Alavi A; Fowler JS; George AE; Reivich M
    Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in glucose metabolism in dementia of the Alzheimer type compared with depression: a preliminary report.
    Guze BH; Baxter LR; Schwartz JM; Szuba MP; Mazziotta JC; Phelps ME
    Psychiatry Res; 1991 Nov; 40(3):195-202. PubMed ID: 1780392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET studies in dementia.
    Herholz K
    Ann Nucl Med; 2003 Apr; 17(2):79-89. PubMed ID: 12790355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
    Heiss WD; Szelies B; Kessler J; Herholz K
    Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of positron emission tomography for diagnosis of dementia.
    Ishii K
    Ann Nucl Med; 2002 Dec; 16(8):515-25. PubMed ID: 12593416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparability of FDG PET studies in probable Alzheimer's disease.
    Herholz K; Perani D; Salmon E; Franck G; Fazio F; Heiss WD; Comar D
    J Nucl Med; 1993 Sep; 34(9):1460-6. PubMed ID: 8355064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
    Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M;
    Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography in the differential diagnosis of organic dementias.
    Heiss WD; Kessler J; Szelies B; Grond M; Fink G; Herholz K
    J Neural Transm Suppl; 1991; 33():13-9. PubMed ID: 1753242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can PET data differentiate Alzheimer's disease from vascular dementia?
    Nagata K; Maruya H; Yuya H; Terashi H; Mito Y; Kato H; Sato M; Satoh Y; Watahiki Y; Hirata Y; Yokoyama E; Hatazawa J
    Ann N Y Acad Sci; 2000 Apr; 903():252-61. PubMed ID: 10818514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.